Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Asset Utilization Ratio (2016 - 2025)

Dexcom (DXCM) has disclosed Asset Utilization Ratio for 14 consecutive years, with 0.61 as the latest value for Q2 2025.

  • On a quarterly basis, Asset Utilization Ratio changed N/A to 0.61 in Q2 2025 year-over-year; TTM through Jun 2025 was 0.61, a N/A change, with the full-year FY2025 number at 0.73, up 14.92% from a year prior.
  • Asset Utilization Ratio was 0.61 for Q2 2025 at Dexcom, down from 0.63 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.63 in Q1 2025 to a low of 0.47 in Q1 2021.
  • A 4-year average of 0.55 and a median of 0.54 in 2023 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: dropped 29.36% in 2021, then increased 10.28% in 2022.
  • Dexcom's Asset Utilization Ratio stood at 0.5 in 2021, then increased by 2.1% to 0.51 in 2022, then grew by 9.39% to 0.56 in 2023, then increased by 8.46% to 0.61 in 2025.
  • Per Business Quant, the three most recent readings for DXCM's Asset Utilization Ratio are 0.61 (Q2 2025), 0.63 (Q1 2025), and 0.56 (Q4 2023).